Enzo Biochem, Inc.
ENZ
$1.02
-$0.025-2.40%
| 01/31/2024 | 10/31/2023 | 07/31/2023 | 04/30/2023 | 01/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 8.55M | 7.81M | 337.00K | 16.11M | 7.51M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 8.55M | 7.81M | 337.00K | 16.11M | 7.51M |
| Cost of Revenue | 4.33M | 4.35M | -4.18M | 14.47M | 4.62M |
| Gross Profit | 4.22M | 3.46M | 4.52M | 1.64M | 2.90M |
| SG&A Expenses | 5.83M | 8.08M | 3.33M | 16.31M | 6.32M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.74M | 13.28M | 255.00K | 31.75M | 12.06M |
| Operating Income | -2.19M | -5.48M | 82.00K | -15.65M | -4.55M |
| Income Before Tax | -863.00K | -5.68M | -1.59M | -15.19M | -2.89M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -863.00K | -5.68M | -1.59M | -15.19M | -2.89M |
| Earnings from Discontinued Operations | -2.20M | -941.00K | 59.02M | -- | -8.43M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.06M | -6.62M | 57.43M | -15.19M | -11.32M |
| EBIT | -2.19M | -5.48M | 82.00K | -15.65M | -4.55M |
| EBITDA | -1.92M | -5.21M | 688.00K | -15.00M | -3.92M |
| EPS Basic | -0.06 | -0.13 | 1.17 | -0.31 | -0.23 |
| Normalized Basic EPS | -0.01 | -0.07 | -0.02 | -0.19 | -0.04 |
| EPS Diluted | -0.06 | -0.13 | 1.17 | -0.31 | -0.23 |
| Normalized Diluted EPS | -0.01 | -0.07 | -0.02 | -0.19 | -0.04 |
| Average Basic Shares Outstanding | 50.49M | 50.18M | 49.16M | 49.38M | 48.73M |
| Average Diluted Shares Outstanding | 50.49M | 50.18M | 49.16M | 49.38M | 48.73M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
